Novel Personalized Cellular Therapy approach for Immune Diseases
| Reference number | |
| Coordinator | TLA TARGETED IMMUNO THERAPIES AB - TLA Targeted Immunotherapies AB |
| Funding from Vinnova | SEK 500 000 |
| Project duration | July 2017 - December 2017 |
| Status | Completed |
Purpose and goal
The aim of the project was to develop a business plan that w ill guide clinical validation and commercialization of the TLA medical device for the treatment of inflammatory bow eldisease (IBD).
Expected results and effects
The business plan has been developed and the market potential has been confirmed. The company is ready to initiate the clinical study. Market analysis has shown that the conditions for validation and commercialization of our product are good.
Planned approach and implementation
The project has been implemented using the Strategic Business Planning Methodology which includes the follow ing activities: Task 1 Strategic Business Review Task 2 Business Model Visioning Task 3 Business Plan Development and Formulation